Apolipoprotein AI-derived pulmonary vascular amyloid in aged dogs

K. E. Roertgen, E. M. Lund, T. D. O'Brien, P. Westermark, D. W. Hayden, K. H. Johnson

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Our studies confirm the common occurrence of a unique form of apolipoprotein AI (apoAI)-derived vascular amyloidosis in dogs that appears to be unrelated to other disease conditions, but is associated with aging. Vascular amyloid deposits were most frequently located within the intima and media of medium-sized pulmonary arteries, and were not confirmed in any other tissues. Pulmonary vascular amyloid immunoreactive with antiserum to purified N-terminal (1-71) canine apoAI amyloid protein was demonstrated retrospectively in 12.8% of necropsied dogs (N = 243) 10 years of age or older. In a subsequent expanded 1-year prospective study of necropsied dogs (N = 231) of all ages, apoAI-derived pulmonary vascular amyloid deposits were demonstrated in 0.7% of dogs <10 years of age and in 22% of dogs 10 years of age or older. The incidence of this form of amyloid in dogs 10 years of age or older was significantly associated with advancing age (P < 0.00001). However, significant differences regarding gender, breed, or the frequency of selected common disease conditions were not observed when the dogs with apoAI-derived amyloid were compared with control dogs. The possibility that this new form of senile apoAI-derived amyloidosis is a manifestation of an age-associated aberration in apoAI metabolism or is related to a mutant form of apoAI is the subject of ongoing investigations.

Original languageEnglish (US)
Pages (from-to)1311-1317
Number of pages7
JournalAmerican Journal of Pathology
Issue number5
StatePublished - 1995


Dive into the research topics of 'Apolipoprotein AI-derived pulmonary vascular amyloid in aged dogs'. Together they form a unique fingerprint.

Cite this